Ivermectin administration is associated with lower gastrointestinal complications and greater ventilator-free days in ventilated patients with COVID-19: A propensity score analysis

INTRODUCTION: COVID-19 patients have been reported to have digestive symptoms with poor outcome. Ivermectin, an antiparasitic drug, has been used in COVID-19 patients. The objective of this study was to evaluate whether ivermectin has effects on gastrointestinal complications and ventilator-free day...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Kentaro, Hirata, Haruhiko, Kabata, Daijiro, Tokuhira, Natsuko, Koide, Moe, Ueda, Akiko, Tachino, Jotaro, Shintani, Ayumi, Uchiyama, Akinori, Fujino, Yuji, Ogura, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718885/
https://www.ncbi.nlm.nih.gov/pubmed/35016823
http://dx.doi.org/10.1016/j.jiac.2021.12.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718885/
https://www.ncbi.nlm.nih.gov/pubmed/35016823
http://dx.doi.org/10.1016/j.jiac.2021.12.024

Ejemplares similares